Bahbak Shariat-Madar

Bahbak Shariat-Madar practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Bahbak Shariat-Madar's NPI, 1922453497, was assigned on May 3, 2016. Bahbak Shariat-Madar graduated from Medical College Of Wisconsin in 2016. Bahbak Shariat-Madar holds Florida license ME148076.

Bahbak Shariat-Madar's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Bahbak Shariat-Madar's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Bahbak Shariat-Madar is also affiliated with Mount Sinai Medical Center. The medical group on file is Select Physical Therapy. Dmand AI also links Bahbak Shariat-Madar to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bahbak Shariat-Madar practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Bahbak Shariat-Madar's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Bahbak Shariat-Madar is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Bahbak Shariat-Madar's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute sinusitis, chronic nasal allergies, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Bahbak Shariat-Madar treats.

CMS data shows 1,385 Medicare services from Bahbak Shariat-Madar across 12 procedure codes in 2024, for 448 Medicare patients. Medicare paid $107,782 for them.

CMS counts 448 Medicare patients who saw Bahbak Shariat-Madar in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bahbak Shariat-Madar's median patient age at 52, with 52% women.

In 2024, Bahbak Shariat-Madar wrote 607 Medicare Part D claims for 299 patients. 95% of them were for generic drugs. CMS names the drug for 537 of them, across 17 drugs with 11 or more claims each, at $11,900 in total drug cost. In 2023, CMS named 474 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Bahbak Shariat-Madar for performance year 2024, reported individually. Bahbak Shariat-Madar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Bahbak Shariat-Madar, published from 2014 to 2016. Bahbak Shariat-Madar's most frequent co-authors are Robert H. Chun, MD, Stephen Conley, MD and Luke A. Jakubowski, MD.

CMS Open Payments shows 78 general payments to Bahbak Shariat-Madar from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 81% of the total. Inspire Medical Systems, Inc. paid the most, $1,572.

Dmand AI lists 1 award for Bahbak Shariat-Madar, most recently Alpha Omega Alpha in 2016.

Bahbak Shariat-Madar graduated from Medical College Of Wisconsin in 2016.

Bahbak Shariat-Madar is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.